The effect of opioid agonists of δ-class DSLET, μ-class DAMGO, κ-class U-69593 and an opioid antagonist, naloxone, on MTT activity of NALM-1 leukemic cells-Reference-Cited by-同舟云学术

The effect of opioid agonists of δ-class DSLET, μ-class DAMGO, κ-class U-69593 and an opioid antagonist, naloxone, on MTT activity of NALM-1 leukemic cells

Published:2002-11 Issue:9 Volume:56 Page:458-462
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Martin-Kleiner I.

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference31 articles.

1. The effect of methionine-enkephalin on nitric oxide-release in mice is age and gender related;Balog;Pharmacol Res,2001

2. In vitro modulation of preleukemic AKR mouse macrophage function by bacterial immunomodulators;Burek;Immunol Lett,1995

3. Chronic exposure to κ-opioids enhances the susceptibility of immortalized neurons (F-11κ7) to apoptosis-inducing drugs by a mechanism that may involve ceramide;Dawson;J Neurochem,1997

4. Mouse strain differences in immunosuppression by opioids in vitro;Eisenstein;J Pharmacol Exp Ther,1995

5. Opioid modulation of immune responses: effect of phagocyte and lymphoid cell populations;Eisenstein;J Neuroimmunol,1998

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Opioid Use in Hematological Malignancies: Clinical, Immunological and Concomitant Aspects;Journal of Hematology;2020

2. Delta opioid peptide DADLE and naltrexone cause cell cycle arrest and differentiation in a CNS neural progenitor cell line;Synapse;2010-04

3. Reduction of cell proliferation and potentiation of Fas-induced apoptosis by the selective kappa-opioid receptor agonist U50 488 in the multiple myeloma LP-1 cells;Journal of Neuroimmunology;2010-03

4. Opioids in pain management of blood-related malignancies;Annals of Hematology;2006-03-30

5. PMA and Doxorubicin Decrease Viability, MTT Activity and Expression of CD10 Marker on NALM-1 Leukemic Cells;Immunopharmacology and Immunotoxicology;2006-01